Search Within

Principal Biostatisticians

  1. "2021"
Formats
  1. Journal Article (29)
  2. Meeting Abstract (24)
  3. Miscellaneous (3)
  4. Review (2)
  5. Correspondence (1)
Groups
  1. Epidemiology and Biostatistics (59)
  2. Surgery (38)
  3. Survivorship Research (29)
  4. Graduate Medical Education (19)
  5. Sloan Kettering Institute Postdocs (19)
  6. Department of Medicine (18)

More Groups

People
  1. Srinivasa Sevilimedu Veeravalli (44)
  2. Monica Morrow (29)
  3. Audree Tadros (17)
  4. Esther Drill (12)
  5. Kate Pawloski (12)
  6. Andrea Barrio (11)

More People

Years
  1. 2021 (59)
Publications
  1. Annals of Surgical Oncology (24)
  2. Journal of Clinical Oncology (5)
  3. Breast Cancer Research and Treatment (3)
  4. Cancer Research (3)
  5. Diagnostics (2)
  6. Hematological Oncology (2)

More Publications

Publishers
  1. Springer (29)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (3)
  4. Elsevier Inc. (3)
  5. MDPI (3)
  6. Wiley Blackwell (3)

More Publishers

Results (59)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COVID-19 impact on interventional pulmonology training
    Journal Article

    Kalchiem-Dekel, O.; Schwalk, A. J.; Patel, N. M.; Lin, I. H.; Beattie, J. A.; Husta, B. C.; Chawla, M.; Sachdeva, A.; Akulian, J. A.; Musani, A. I.; more...
    ATS Scholar (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Real-world assessment of patient care and practice efficiency with the introduction of subcutaneous rituximab
    Journal Article

    Drill, E.; Qiu, A.; Shapouri, S.; Tu My, T.; Ravelo, A.; Schade, J.; Dawson, K.; Matasar, M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy - A rare event
    Journal Article

    Barrio, A. V.; Montagna, G.; Mamtani, A.; Sevilimedu, V.; Edelweiss, M.; Capko, D.; Cody, H. S. 3rd; El-Tamer, M.; Gemignani, M. L.; Heerdt, A.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • IVAC with or without rituximab for relapsed or refractory B-cell non-Hodgkin lymphomas: Real-world experience in the modern era
    Journal Article

    Buege, M. J.; Dao, P. H.; Drill, E.; LeVoir, A.; Pak, T.; Peterson, T. J.; Straus, D. J.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Post-discharge non-steroidal anti-inflammatory drugs are not associated with risk of hematoma after lumpectomy and sentinel lymph node biopsy with multimodal analgesia
    Miscellaneous

    Pawloski, K. R.; Matar, R.; Sevilimedu, V.; Tadros, A. B.; Kirstein, L. J.; Cody, H.; Van Zee, K. J.; Morrow, M.; Moo, T. A.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Local recurrence is frequent after heroic mastectomy for classically inoperable breast cancers
    Miscellaneous

    Mamtani, A.; Sevilimedu, V.; Vincent, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Margin width and local recurrence in patients undergoing breast conservation after neoadjuvant chemotherapy
    Miscellaneous

    Mrdutt, M.; Heerdt, A.; Sevilimedu, V.; Mamtani, A.; Barrio, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Assessing PD-L1 expression status using radiomic features from contrast-enhanced breast MRI in breast cancer patients: Initial results
    Journal Article

    Lo Gullo, R.; Wen, H.; Reiner, J. S.; Hoda, R.; Sevilimedu, V.; Martinez, D. F.; Thakur, S. B.; Jochelson, M. S.; Gibbs, P.; Pinker, K.
    Cancers (2021)

    Fulltext@MSK | Save
  • Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Grisham, R. N.; Vergote, I.; Banerjee, S. N.; Drill, E. N.; Fabbro, M.; Mirza, M. R.; Romero, I.; Coleman, R. L.; Oza, A. M.; Hilpert, F.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save